IBDEI0NM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11025,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,11026,0)
 ;;=Z95.3^^47^524^68
 ;;^UTILITY(U,$J,358.3,11026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11026,1,3,0)
 ;;=3^Presence of Xenogenic Heart Valve
 ;;^UTILITY(U,$J,358.3,11026,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,11026,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,11027,0)
 ;;=I27.9^^47^524^69
 ;;^UTILITY(U,$J,358.3,11027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11027,1,3,0)
 ;;=3^Pulmonary Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,11027,1,4,0)
 ;;=4^I27.9
 ;;^UTILITY(U,$J,358.3,11027,2)
 ;;=^5007154
 ;;^UTILITY(U,$J,358.3,11028,0)
 ;;=I27.0^^47^524^70
 ;;^UTILITY(U,$J,358.3,11028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11028,1,3,0)
 ;;=3^Pulmonary Hypertension,Primary
 ;;^UTILITY(U,$J,358.3,11028,1,4,0)
 ;;=4^I27.0
 ;;^UTILITY(U,$J,358.3,11028,2)
 ;;=^265310
 ;;^UTILITY(U,$J,358.3,11029,0)
 ;;=I73.00^^47^524^71
 ;;^UTILITY(U,$J,358.3,11029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11029,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,11029,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,11029,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,11030,0)
 ;;=R57.0^^47^524^72
 ;;^UTILITY(U,$J,358.3,11030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11030,1,3,0)
 ;;=3^Shock,Cardiogenic
 ;;^UTILITY(U,$J,358.3,11030,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,11030,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,11031,0)
 ;;=R57.1^^47^524^73
 ;;^UTILITY(U,$J,358.3,11031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11031,1,3,0)
 ;;=3^Shock,Hypovolemic
 ;;^UTILITY(U,$J,358.3,11031,1,4,0)
 ;;=4^R57.1
 ;;^UTILITY(U,$J,358.3,11031,2)
 ;;=^60845
 ;;^UTILITY(U,$J,358.3,11032,0)
 ;;=R57.9^^47^524^74
 ;;^UTILITY(U,$J,358.3,11032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11032,1,3,0)
 ;;=3^Shock,Unspec
 ;;^UTILITY(U,$J,358.3,11032,1,4,0)
 ;;=4^R57.9
 ;;^UTILITY(U,$J,358.3,11032,2)
 ;;=^5019527
 ;;^UTILITY(U,$J,358.3,11033,0)
 ;;=R55.^^47^524^75
 ;;^UTILITY(U,$J,358.3,11033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11033,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,11033,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,11033,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,11034,0)
 ;;=I78.0^^47^524^76
 ;;^UTILITY(U,$J,358.3,11034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11034,1,3,0)
 ;;=3^Telangiectasia,Hereditary Hemorrhagic
 ;;^UTILITY(U,$J,358.3,11034,1,4,0)
 ;;=4^I78.0
 ;;^UTILITY(U,$J,358.3,11034,2)
 ;;=^117566
 ;;^UTILITY(U,$J,358.3,11035,0)
 ;;=I73.1^^47^524^20
 ;;^UTILITY(U,$J,358.3,11035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11035,1,3,0)
 ;;=3^Buerger's Disease
 ;;^UTILITY(U,$J,358.3,11035,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,11035,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,11036,0)
 ;;=G45.9^^47^524^77
 ;;^UTILITY(U,$J,358.3,11036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11036,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,11036,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,11036,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,11037,0)
 ;;=G45.8^^47^524^78
 ;;^UTILITY(U,$J,358.3,11037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11037,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
 ;;^UTILITY(U,$J,358.3,11037,1,4,0)
 ;;=4^G45.8
 ;;^UTILITY(U,$J,358.3,11037,2)
 ;;=^5003958
 ;;^UTILITY(U,$J,358.3,11038,0)
 ;;=I83.019^^47^524^81
 ;;^UTILITY(U,$J,358.3,11038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11038,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,11038,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,11038,2)
 ;;=^5007979
